$6.93 +0.03 (%) Arrowhead Research Corp - NASDAQ

Jun. 30, 2015 | 12:50 PM

Partner Headlines

  1. Arrowhead Receives Regulatory Clearance to Begin Additional Phase 2b Studies of Hepatitis B Candidate ARC-520

    Benzinga | Jun. 17, 2015 | 07:30AM EST
  2. Arrowhead Presents Data on Potential RNAi Candidate Targeting Factor 12 Mediated Angioedemic and Thromboembolic Diseases

    Benzinga | May. 6, 2015 | 15:19PM EST
  3. Morning Market Losers

    Benzinga | Apr. 14, 2015 | 09:52AM EST
  4. Morning Market Gainers

    Benzinga | Apr. 13, 2015 | 09:41AM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 13, 2015 | 08:12AM EST
  6. The News That Should Move Arrowhead Research Today

    Benzinga | Feb. 10, 2015 | 07:09AM EST
  7. Arrowhead Research Shares Seeing Significant Short Interest

    Benzinga | Feb. 2, 2015 | 11:46AM EST
  8. Deutsche Bank Downgrades Arrowhead, Says 2015 Is The 'Show-Me Year'

    Benzinga | Jan. 22, 2015 | 09:22AM EST
  9. Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4%

    Benzinga | Jan. 12, 2015 | 12:55PM EST
  10. Mid-Morning Market Update: Markets Tumble; Shire To Acquire NPS Pharmaceuticals For $5.2 Billion

    Benzinga | Jan. 12, 2015 | 11:37AM EST
  11. Morning Market Losers

    Benzinga | Jan. 12, 2015 | 09:54AM EST
  12. Merger Monday Moving Stocks Monday Morning

    Benzinga | Jan. 12, 2015 | 09:48AM EST
  13. Arrowhead Research Tumbles 20% Following FDA News

    Benzinga | Jan. 12, 2015 | 09:13AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 12, 2015 | 08:15AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 2, 2015 | 08:38AM EST
  16. Biotech Stocks Make Big Moves In Final Days Of 2014

    Benzinga | Dec. 31, 2014 | 09:41AM EST
  17. Arrowhead Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi Therapeutic ARC-AAT

    Benzinga | Nov. 18, 2014 | 07:30AM EST
  18. Arrowhead Offers Data on ARC-520, ARC-AAT at AASLD The Liver Meeting

    Benzinga | Nov. 10, 2014 | 09:18AM EST
  19. Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR

    GuruFocus | Oct. 20, 2014 | 11:40AM EST
  20. The 3 Most Volatile Biotech Stocks

    Benzinga | Oct. 14, 2014 | 12:42PM EST
  21. Arrowhead Research Corp Hammered On Drug News; Deutsche Bank Lowers Price Target

    Benzinga | Oct. 8, 2014 | 14:32PM EST
  22. Midday Losers From October 8 - Arrowhead Research Corp, A10 Networks Inc. And More

    Benzinga | Oct. 8, 2014 | 13:49PM EST
  23. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  24. Arrowhead Research Corp Down Big On Disappointing Hepatitis B Drug Data

    Benzinga | Oct. 8, 2014 | 11:41AM EST
  25. Morning Market Losers

    Benzinga | Oct. 8, 2014 | 09:48AM EST
  26. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 8, 2014 | 08:09AM EST
  27. Top 5 Biotech Stocks Over The Past Year

    Benzinga | Oct. 6, 2014 | 14:28PM EST
  28. Arrowhead Research Corp Heads Higher After Breakout

    Benzinga | Sep. 4, 2014 | 14:51PM EST
  29. Arrowhead Research Corp Shares Push Over Resistance Level As Momentum Continues

    Benzinga | Sep. 3, 2014 | 12:54PM EST
  30. Winners & Losers From Tuesday, August 26

    Benzinga | Aug. 26, 2014 | 16:02PM EST
  31. Deutsche Bank Sees Achillion, Arrowhead As Potential Takeover Targets

    Benzinga | Aug. 26, 2014 | 13:37PM EST
  32. Morning Market Movers

    Benzinga | Jul. 29, 2014 | 09:42AM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 29, 2014 | 08:13AM EST
  34. Arrowhead Research Up Over 6% Following CNBC Comments

    Benzinga | Jul. 9, 2014 | 11:51AM EST
  35. 4 Biotech Stocks With Big Money Coming In

    Benzinga | Jun. 30, 2014 | 15:50PM EST
  36. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 19, 2014 | 08:13AM EST
  37. Mid-Afternoon Market Update: Markets Trade Up as Bank of America Shares Remain Down

    Benzinga | Apr. 16, 2014 | 15:40PM EST
  38. Mid-Day Market Update: Yahoo Jumps On Upbeat Results; ASML Shares Decline

    Benzinga | Apr. 16, 2014 | 12:38PM EST
  39. Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as Talk of a Pull-Back is Widespread

    Benzinga | Apr. 15, 2014 | 15:59PM EST
  40. Deutsche Bank Remains Positive on Arrowhead Research Despite Weakness

    Benzinga | Mar. 25, 2014 | 08:03AM EST
  41. Deutsche Bank Defends Arrowhead Amid ~16% Decline, Reiterates Buy

    Benzinga | Mar. 24, 2014 | 18:10PM EST
  42. Arrowhead Surges As Analysts Laud Hepatitis B Drug

    IBD | Mar. 5, 2014 | 11:14AM EST
  43. UPDATE: Soaring 19%, Deutsche Bank Initiates Coverage on Arrowhead Research

    Benzinga | Mar. 5, 2014 | 10:39AM EST
  44. UPDATE: Deutsche Bank Initiates Coverage on Arrowhead Research on Good Potential

    Benzinga | Mar. 5, 2014 | 10:27AM EST
  45. Benzinga's Volume Movers

    Benzinga | Mar. 5, 2014 | 10:24AM EST
  46. Mid-Morning Market Update: Markets Mostly Flat; Brown-Forman Posts Higher Profit

    Benzinga | Mar. 5, 2014 | 10:22AM EST
  47. Morning Movers for Mar. 5, 2014: FCEL, ARWR, SWHC, CPST Moving Higher

    Benzinga | Mar. 5, 2014 | 09:52AM EST
  48. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 5, 2014 | 08:08AM EST
  49. Benzinga's Top Initiations

    Benzinga | Mar. 5, 2014 | 07:59AM EST
  50. After-Hours Movers: BV, SWHC, AVAV, CTIC Moving Higher, HCI, BOBE, CHEF, THOR Lower

    Benzinga | Mar. 4, 2014 | 17:24PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!